Medication Monitor



Generic Name (Trade Name—Company)
Notes
June 2, 2018

Fluticasone propionate nasal spray

(No trade names—Apotex Corp.)
Nasal spray may contain small glass particles

FDA announced a recall of one lot of fluticasone propionate nasal spray 50 mcg per spray, 120 metered sprays (lot# NJ4501, expiration date July 2020). The product may contain small glass particles that could block the actuator, impact the functionality of the pump, and cause local trauma to the nasal mucosa in individuals who use it.

The issue was discovered through a customer complaint. 

The spray is indicated for treatment of seasonal and perennial allergic rhinitis and management of sinus pain and pressure associated with allergic rhinitis in patients 4 to 17 years of age.

Patients, wholesalers, retailers, hospitals, or institutions should stop use and distribution of the remaining units and quarantine immediately.